Valuation Regencell Bioscience Holdings Limited
Stocks
RGC
KYG7487R1002
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 5.920 USD | +2.25% |
|
+3.14% | -71.81% |
Company Valuation: Regencell Bioscience Holdings Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 450.3 | 299.8 | 43.72 | 8,426 |
| Change | - | -33.42% | -85.42% | 19,171.44% |
| Enterprise Value (EV) 1 | 434.7 | 288.7 | 35.85 | 8,422 |
| Change | - | -33.58% | -87.58% | 23,393.1% |
| P/E | -59.5x | -51.1x | -10.2x | -2,351x |
| PBR | 26.4x | 24.9x | 5.32x | 1,734x |
| PEG | -0x | 2.3x | 0.4x | 140.9x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | -58.2x | -48.3x | -8.09x | -2,281x |
| EV / EBIT | -57.1x | -46x | -7.57x | -2,234x |
| EV / FCF | -162x | -127x | -19.1x | -5,587x |
| FCF Yield | -0.62% | -0.79% | -5.25% | -0.02% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.0153 | -0.0119 | -0.008699 | -0.007248 |
| Distribution rate | - | - | - | - |
| Net sales | - | - | - | - |
| EBITDA 1 | -7.468 | -5.981 | -4.431 | -3.692 |
| EBIT 1 | -7.618 | -6.274 | -4.737 | -3.77 |
| Net income 1 | -7.446 | -5.871 | -4.302 | -3.584 |
| Net Debt 1 | -15.65 | -11.1 | -7.875 | -4.353 |
| Reference price 2 | 0.911 | 0.606 | 0.088 | 17.040 |
| Nbr of stocks (in thousands) | 494,489 | 494,489 | 494,489 | 494,489 |
| Announcement Date | 10/31/22 | 10/27/23 | 10/25/24 | 10/31/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.87B | |
| 31.88x | 5.74x | 17.19x | 1.02% | 46.28B | |
| 34.31x | 3.31x | 14.29x | -.--% | 43.85B | |
| -19.53x | 224.63x | -20.86x | -.--% | 40.93B | |
| 45.96x | 5.31x | 29.04x | -.--% | 39.89B | |
| 27.09x | 7.81x | 19.95x | 0.42% | 29.5B | |
| 34.82x | 5.71x | 25.95x | -.--% | 17.09B | |
| 25.48x | 2.19x | 9.51x | 1.05% | 15.22B | |
| -55.89x | 9.19x | 224.28x | -.--% | 14.05B | |
| Average | 15.51x | 32.99x | 39.92x | 0.31% | 27.74B | |
| Weighted average by Cap. | 20.30x | 41.76x | 24.53x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RGC Stock
- Valuation Regencell Bioscience Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
